Niall Ashfield investigates how cancer cells develop resistance to treatment. By recreating drug resistance in laboratory-grown cancer cells, his research examines the cellular changes that allow tumours to survive therapy. Identifying vulnerabilities in resistant cells could reveal alternative treatments, improve patient outcomes and support collaborations with pharmaceutical companies worldwide.

Rosie Gigila investigates cognitive dysfunction in neurological conditions including multiple sclerosis and motor neuron disease. By examining brain activity associated with changes in memory, learning and attention, her research aims to develop improved measurement tools for tracking cognitive impairment, predicting changes and evaluating treatment effectiveness in future clinical trials.